Modulation of GABA and glycine receptors in rat pyramidal hippocampal neurones by 3 alpha 5 beta-pregnanolone derivatives

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F18%3A00492171" target="_blank" >RIV/61388963:_____/18:00492171 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.neuint.2018.06.002" target="_blank" >http://dx.doi.org/10.1016/j.neuint.2018.06.002</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.neuint.2018.06.002" target="_blank" >10.1016/j.neuint.2018.06.002</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Modulation of GABA and glycine receptors in rat pyramidal hippocampal neurones by 3 alpha 5 beta-pregnanolone derivatives

Popis výsledku v původním jazyce

The ability of pregnanolone glutamate (PA-Glu), pregnanolone hemisuccinate (PA-hSuc) and pregnanolone hemipimelate (PA-hPim), neuroactive steroids with a negative modulatory effect on excitatory N-methyl-D-aspartate receptors, to influence the functional activity of inhibitory gamma-aminobutyric acid and glycine receptors was estimated. The GABA- and glycine-induced chloride currents (I-GABA and I-Gly) were measured in isolated pyramidal neurons of the rat hippocampus using the patch-clamp technique. Compound PA-Glu was found to potentiate I-GABA and to inhibit loy, while PA-hSuc and PA-hPim inhibited both I-GABA and I-Gly. Moreover, PA-Glu, PA-hSuc, and PA-hPim had a greater effect on desensitization than on the peak amplitude of I-Gly. At a high concentration of glycine (500 mu M), the effect of neurosteroids on the peak amplitude of I-Gly disappeared, and the acceleration of desensitization remained. The conversion of PA-Glu into androstane glutamate (AND-Glu), an analogue that lacks the C-17 acetyl moiety, completely eliminated the effects on these receptors. Our results indicate that the C-17 acetyl moiety is crucial for the action on I-GABA and I-Gly. Our results indicate that the pregnanolone derivatives, in contrast to the androstane analogues, modulate I-GABA and I-Gly at low micromolar concentrations and this family of neurosteroids can be useful for future structure-activity relationship studies of the steroid modulation of other receptor types.

Název v anglickém jazyce

Modulation of GABA and glycine receptors in rat pyramidal hippocampal neurones by 3 alpha 5 beta-pregnanolone derivatives

Popis výsledku anglicky

The ability of pregnanolone glutamate (PA-Glu), pregnanolone hemisuccinate (PA-hSuc) and pregnanolone hemipimelate (PA-hPim), neuroactive steroids with a negative modulatory effect on excitatory N-methyl-D-aspartate receptors, to influence the functional activity of inhibitory gamma-aminobutyric acid and glycine receptors was estimated. The GABA- and glycine-induced chloride currents (I-GABA and I-Gly) were measured in isolated pyramidal neurons of the rat hippocampus using the patch-clamp technique. Compound PA-Glu was found to potentiate I-GABA and to inhibit loy, while PA-hSuc and PA-hPim inhibited both I-GABA and I-Gly. Moreover, PA-Glu, PA-hSuc, and PA-hPim had a greater effect on desensitization than on the peak amplitude of I-Gly. At a high concentration of glycine (500 mu M), the effect of neurosteroids on the peak amplitude of I-Gly disappeared, and the acceleration of desensitization remained. The conversion of PA-Glu into androstane glutamate (AND-Glu), an analogue that lacks the C-17 acetyl moiety, completely eliminated the effects on these receptors. Our results indicate that the C-17 acetyl moiety is crucial for the action on I-GABA and I-Gly. Our results indicate that the pregnanolone derivatives, in contrast to the androstane analogues, modulate I-GABA and I-Gly at low micromolar concentrations and this family of neurosteroids can be useful for future structure-activity relationship studies of the steroid modulation of other receptor types.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

10608 - Biochemistry and molecular biology

Projekt

<a href="/cs/project/TE01020028" target="_blank" >TE01020028: Centrum vývoje originálních léčiv</a><br>

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Neurochemistry International

ISSN

0197-0186

e-ISSN

—

Svazek periodika

118

Číslo periodika v rámci svazku

Sep

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

7

Strana od-do

145-151

Kód UT WoS článku

000439674200016

EID výsledku v databázi Scopus

2-s2.0-85048388816